Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abboud

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Angewandte Chemie (International Ed. in English)|March 3, 2017
<sup>19</sup> F-NMR Reveals the Role of Mobile Loops in Product and Inhibitor Binding by the São Paulo Metallo-β-LactamaseMartine I Abboud, Philip Hinchliffe, Jürgen Brem, et al.
Chemmedchem|November 1, 2018
A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular ImagingMarleen Mayer, Kerstin Fey, Eva Heinze, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2013
Human de novo papillary renal-cell carcinomas in a kidney graft: evidence of recipient origin with adenoma-carcinoma sequenceJ Verine, M Varna, P Ratajczak, et al.
Journal of Medicinal Chemistry|December 23, 2017
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase InhibitorsRicky Cain, Jürgen Brem, David Zollman, et al.
Chemical Communications (Cambridge, England)|May 5, 2017
Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibitionGuo-Bo Li, Jürgen Brem, Robert Lesniak, et al.
Chemical Communications (Cambridge, England)|March 10, 2018
2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2Martine I Abboud, Tom E McAllister, Ivanhoe K H Leung, et al.
Chemmedchem|November 22, 2019
Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain InhibitorsJames P Holt-Martyn, Rasheduzzaman Chowdhury, Anthony Tumber, et al.
Nature Communications|August 27, 2016
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylasesRasheduzzaman Chowdhury, Ivanhoe K H Leung, Ya-Min Tian, et al.
Scientific Reports|February 3, 2025
Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effectsMichael I Koukourakis, Alexandra Giatromanolaki, Christos E Zois, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|March 3, 2017
<sup>19</sup> F-NMR Reveals the Role of Mobile Loops in Product and Inhibitor Binding by the São Paulo Metallo-β-LactamaseMartine I Abboud, Philip Hinchliffe, Jürgen Brem, et al.
Chemmedchem|November 1, 2018
A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular ImagingMarleen Mayer, Kerstin Fey, Eva Heinze, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2013
Human de novo papillary renal-cell carcinomas in a kidney graft: evidence of recipient origin with adenoma-carcinoma sequenceJ Verine, M Varna, P Ratajczak, et al.
Journal of Medicinal Chemistry|December 23, 2017
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase InhibitorsRicky Cain, Jürgen Brem, David Zollman, et al.
Chemical Communications (Cambridge, England)|May 5, 2017
Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibitionGuo-Bo Li, Jürgen Brem, Robert Lesniak, et al.
Chemical Communications (Cambridge, England)|March 10, 2018
2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2Martine I Abboud, Tom E McAllister, Ivanhoe K H Leung, et al.
Chemmedchem|November 22, 2019
Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain InhibitorsJames P Holt-Martyn, Rasheduzzaman Chowdhury, Anthony Tumber, et al.
Nature Communications|August 27, 2016
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylasesRasheduzzaman Chowdhury, Ivanhoe K H Leung, Ya-Min Tian, et al.
Scientific Reports|February 3, 2025
Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effectsMichael I Koukourakis, Alexandra Giatromanolaki, Christos E Zois, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 6